Delegates at the recent 93rd Congress of the European Atherosclerosis Society (4-7 May 2025, Glasgow, UK) were left in no doubt of the importance of Lp(a) as a key risk factor for atherosclerotic cardiovascular disease (ASCVD), with new data from a major US study showing Lp(a) as a driver of recurrent ASCVD events. Further presentations linked Lp(a) with coronary events in the presence of few if any traditional risk factors, and with vulnerable plaques. Researchers also reinforced the importance of Lp(a) testing as early in life as possible and provided reassuring evidence that low Lp(a) levels are not linked to dementia.
Read the reports:
- Lp(a) drives recurrent ASCVD events
- High Lp(a) linked to CHD events in absence of traditional risk factors
- Low Lp(a) does not increase dementia risk
- Identifying children with elevated Lp(a)
- Elevated Lp(a) linked to vulnerable plaque
Reporting by Jenny Bryan
